SELOKEN

This brand name is authorized in Austria, Brazil, Finland, France, Italy, Japan, Mexico

Active ingredients

The drug SELOKEN contains one active pharmaceutical ingredient (API):

1 Metoprolol UNII TH25PD4CCB - METOPROLOL SUCCINATE

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation. Read about Metoprolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB02	Metoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502303304152318, 502315030025103
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 422022
Country: FR	Base de données publique des médicaments	Identifier(s): 68179830, 68679426
Country: IT	Agenzia del Farmaco	Identifier(s): 023616028, 023616042
Country: JP	医薬品医療機器総合機構	Identifier(s): 2149010F1025, 2149010G1047
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 172M91